Press release
Advancements in technologies have enabled Bio-Synthesis to expand their product line to include Long Oligo Synthesis
Bio-Synthesis offers long oligo synthesis and gene synthesis services as control templates, cloning, mutagenesis, gene expression and other demanding applications. BSI has provided thousands of high-fidelity synthesis of very long oligos, DNA UbermersTM, with impeccable quality and services which are unmatched by other suppliers.Longer constructs that required more choices like palindromes for restriction enzymes give researchers more flexibility. DNA UbermersTM are also used as an internal control template with or without certain SNP's and have been use in amplification reactions like Real-Time PCR and qPCR. All Oligo UbermersTM are delivered deprotected, desalted to remove small molecular impurities, and PAGE purified for extremely high purity needs. For even greater convenience, all Oligo UbermersTM are delivered lyophilized.
While there has been significant demand for long oligos, the yields in conventional DNA synthesis and the associated side reactions have been previously limited due to the length. Bio-Synthesis's expertise in artificial gene synthesis and microarray development provides the ability to synthesize thousands of single strand synthetic long DNA oligos using the best DNA synthesis reagents available. Optimized long oligo synthesis protocols permit high quality DNA oligomer with superior coupling efficiency through an entire DNA synthesis reaction. Each long custom DNA oligo is meticulously monitored during synthesis and controlled according to Bio-Synthesis’s stringent quality assurance and quality control standards.
As the capabilities of RNA analysis expand, the need to obtain a standardized RNA fragment has become increasingly important in the development of molecular diagnostic techniques. RNA oligos can be added and quantified at will, making them very important as reliable controls for each step of the RT-PCR protocol to ensure the accuracies of diagnostic test results. Many RNA based applications not only uses short RNA but very long RNA sequences. The typical RNA control fragment for RT-PCR, Spike-in control or transcript/mRNA for protein synthesis, require RNA fragments between 200 bases and a few thousand bases. Bio-Synthesis is uniquely positioned and capable to synthesizing long RNA fragment with greater length, quality and fast turnaround time.
About Bio-Synthesis
Bio-Synthesis is a manufacturer of custom peptide synthesis, antibodies, bioconjugates, DNA, RNA, PNA, organic synthesis, microarrays, gene synthesis, cloning, detection kits, cell line authentication, and a diverse number of bimolecular products for the biomedical/life science community worldwide.
With over 27 years of experience producing custom products for both research and pharmaceutical use, BSI has developed a reputation for both small and large scale synthesis using optimal processes that meet your specifications. BSI is a U.S. based company, therefore all products are exclusively manufactured at the state-of-the-art facilities in Lewisville, Texas.
Bio-Synthesis, Inc.
612 East Main Street
Lewisville, TX 75057
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Advancements in technologies have enabled Bio-Synthesis to expand their product line to include Long Oligo Synthesis here
News-ID: 219763 • Views: …
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…